Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Clinical trial NCT06066216 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06066216
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-10-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.